Clinical Trials on Sindrome WAGR

Total 33970 results

National Cancer Institute (NCI)

Completed

Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes

Hamartoma Syndrome, Multiple | Cowden's Disease

United States
University of Colorado, Denver

Approved for marketing

Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome (3 4-DAP)

Lambert Eaton Myasthenic Syndrome

United States
Jacobus Pharmaceutical

Completed

Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome (DAPPER)

Lambert-Eaton Myasthenic Syndrome | Eaton-Lambert Myasthenic Syndrome

United States
David P. Richman, MD
Jacobus Pharmaceutical

No longer available

Treatment of Lambert-Eaton Syndrome With 3,4 DAP

Lambert Eaton Myasthenic Syndrome

United States
Dr Yves JACOT, MD
Projet Suisse d'Assistance Medicale

Unknown

Shock-Waves to Treat Fibromyalgia Pain (SWPW-FPS)

Fibromyalgia | Central Sensitization | Myofascial Pain Syndrome | MSK: Chronic Pain Syndromes (E.G. Fibromyalgia)
Poitiers University Hospital

Completed

Interest of Treatment of Obstructive Sleep Apnea Syndrome by Constant CPAP and Auto CPAP (PREDIVARIUS)

Obstructive Sleep Apnea Syndromes
University Hospital, Grenoble
Icadom; DOCAPOST; Sunrise

Completed

Sunrise® a New Medical Device to Diagnose Sleep Apnea Syndrome (SENSAPNEA)

Sleep Apnea Syndrome, Obstructive

France
Catalyst Pharmaceuticals, Inc.

Completed

A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)

Lambert Eaton Myasthenic Syndrome

United States, Spain, Serbia, Russian Federation, Hungary, France, Germany, Poland
Mayo Clinic

Recruiting

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Hematologic Neoplasms | Myeloid Malignancy | Cytopenia | Bone Marrow Failure Syndrome | Clonal Cytopenia of Undetermined Significance | Clonal Hematopoiesis of Indeterminate Potential | Low Risk Myelodysplastic Syndrome | Inherited Bone Marrow Failure Syndrome | Clonal Expansion | Hereditary Neoplastic... and other conditions

United States
OphRx Ltd.

Completed

A Feasibility Study to Evaluate the Tolerability of Oph1 Compared to Restasis in Healthy Volunteers

Dry Eye Syndromes

Israel
University of New Mexico

Withdrawn

Punctal Plugs and Iodine Related Discomfort

Dry Eye Syndromes

United States
Laboratorios Sophia S.A de C.V.

Active, not recruiting

Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel (PRO-165)

Dry Eye Syndromes

Mexico
GL Pharm Tech Corporation

Completed

A Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of GLH8NDE After Single and Mutiple Ocular Administrations in Healthy Korean and Caucasian Volunteers

Dry Eye Syndromes

Korea, Republic of
Alcon Research

Completed

Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%

Dry Eye Syndrome
Novaliq GmbH

Completed

NovaTears® Eye Drops Observational Study NT-003

Dry Eye Syndromes

Germany
University of Waterloo
Alcon Research

Completed

A Pilot Study on the Use of a Sensory Panel to Assess Comfort Between Three Different Contact Lenses (NAISMITH)

Dry Eye Syndromes

Canada
Dong-A ST Co., Ltd.

Completed

Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers

Dry Eye Syndrome

Korea, Republic of
Alcon Research

Completed

Residence Time Evaluation of Systane Ultra Lubricant Eye Drops vs. Hialid and Saline

Dry Eye Syndrome
University of Campinas, Brazil
Merck Sharp & Dohme LLC

Completed

The Effects of BAK on the Blood Aqueous Barrier of Pseudophakic Patients

Dry Eye Syndromes

Brazil
Allergan

Completed

Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients

Dry Eye Syndromes

United States
Allergan

Completed

Efficacy and Acceptability of Two Lubricant Eye Drops

Dry Eye Syndromes

United States
Pharmaceutical Research Network

Completed

Soothe Versus Refresh

Dry Eye Syndromes

United States
Olympic Ophthalmics, Inc.

Recruiting

A Usability Study of External Neuromodulation With iTEAR100 Generation 2

Dry Eye Syndromes

United States
Daewoong Bio Inc.

Completed

Pharmacokinetics, Safety, and Tolerability of rhEGF Eye Drops in Healthy Male Subjects

Dry Eye Syndromes

Korea, Republic of
Kukje Pharma

Completed

[KSR-001-P01]Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristic of KSR-001

Dry Eye Syndromes

Korea, Republic of
University of Washington
National Eye Institute (NEI); National Institutes of Health (NIH)

Completed

Ocular Surface Microbiome

Dry Eye Syndromes

United States
Medical University of Vienna
Croma-Pharma GmbH

Completed

Assessment of Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Subjects While Wearing Contact Lenses and Before Insertion of Contact Lenses

Dry Eye Syndrome

Austria
Innovative Medical

Completed

Refractive Surgery and Optive Compatibility Study

Dry Eye Syndromes

United States
SIFI SpA

Completed

Investigation of Preservative-Free Ophthalmic Solution in Ocular Dryness

Dry Eye Syndromes

Spain
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety Study of OPC-12759 Ophthalmic Solution

Dry Eye Syndromes

Japan
Allergan

Completed

Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy (IMPACT)

Dry Eye Syndromes

United States
Sight Sciences, Inc.

Unknown

Pilot Study of TearCare System - Long-Term Extension

Dry Eye Syndromes

United States
Allergan

Completed

Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis® (EMPOWER)

Dry Eye Syndromes

United States
Novaliq GmbH

Completed

NovaTears® Eye Drops Observational Study NT-002

Dry Eye Syndromes

Germany
Meir Medical Center

Unknown

Estrogen and the Outer Eye in Women During Fertility Treatment

Dry Eye Syndromes
Alcon Research

Completed

Systane Clinical Experience Study

Dry Eye Syndrome
Instituto de Investigación Biomédica de Salamanca
Carlos III Health Institute

Recruiting

Unified platforM for a Better integRal Evaluation of MyeLodyspLastic Syndromes in SpAin-Strategy for Unraveling Personalized genoMic Medicine in Public heAlth System (UMBRELLA-SUMMA) (UMBRELLA-SUMMA)

Myelodysplastic Syndromes

Spain
Kind Pharmaceuticals LLC

Not yet recruiting

A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome

Myelodysplastic Syndromes
National Cancer Institute (NCI)

Recruiting

Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes

Myelodysplastic Syndromes

United States
Syros Pharmaceuticals

Recruiting

Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome

Myelodysplastic Syndromes

United States, Spain, Belgium, Israel, France, United Kingdom, Austria, Czechia, Italy, Poland, Canada, Hungary, Germany
Gruppo Italiano Malattie EMatologiche dell'Adulto

Recruiting

Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients

Myelodysplastic Syndromes

Italy
Syntrix Biosystems, Inc.
Johns Hopkins University; Mayo Clinic; National Heart, Lung, and Blood Institute... and other collaborators

Recruiting

Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

Myelodysplastic Syndromes

United States
Centre Hospitalier Universitaire, Amiens

Recruiting

Immunophenotyping of Blood Cells in the Diagnosis Work-up of Myelodysplastic Syndromes (MODIFY)

Myelodysplastic Syndromes

France
The University of Hong Kong

Recruiting

Clinical and Genomic Registry of MDS in Asia

Myelodysplastic Syndromes

Hong Kong
Washington University School of Medicine
Sunesis Pharmaceuticals

Completed

Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes

Myelodysplastic Syndromes

United States
Sclnow Biotechnology Co., Ltd.

Suspended

Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes

China
NYU Langone Health
Perlmutter Cancer Center

Completed

A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations

Myelodysplastic Syndromes

United States
Gilead Sciences

Terminated

Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS) (ENHANCE)

Myelodysplastic Syndromes

United States, Spain, Belgium, Australia, France, Hong Kong, Hungary, Finland, New Zealand, Germany, Netherlands, United Kingdom, Italy, Switzerland, Portugal, Canada, Austria, Czechia, Norway, Poland, Turkey
Celgene

Completed

Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes

Myelodysplastic Syndromes

United States, United Kingdom, Australia, Poland, Spain, Belgium, Italy, Germany, France, Canada
Sohag University

Completed

Clinical and Laboratory Parameters of Myelodysplastic Syndromes at Upper Egypt

Myelodysplastic Syndromes

Egypt

Clinical Trials on Sindrome WAGR

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations